Use of Novel Electrogram "Lumipoint" Algorithm to Detect Critical Isthmus and Abnormal Potentials for Ablation in Ventricular Tachycardia.


Journal

JACC. Clinical electrophysiology
ISSN: 2405-5018
Titre abrégé: JACC Clin Electrophysiol
Pays: United States
ID NLM: 101656995

Informations de publication

Date de publication:
04 2019
Historique:
received: 06 11 2018
revised: 08 01 2019
accepted: 17 01 2019
entrez: 20 4 2019
pubmed: 20 4 2019
medline: 4 7 2020
Statut: ppublish

Résumé

This study reports the use of a novel "Lumipoint" algorithm in ventricular tachycardia (VT) ablation. Automatic mapping systems aid rapid acquisition of activation maps. However, they may annotate farfield rather than nearfield signal in low voltage areas, making maps difficult to interpret. The Lumipoint algorithm analyzes the complete electrogram tracing and therefore includes nearfield signals in its analysis. Twenty-two patients with ischemic cardiomyopathy and 5 with dilated cardiomyopathy underwent mapping using the ultra-high density Rhythmia system. Lumipoint algorithms were applied retrospectively. In all left ventricular substrate maps, changing the window of interest to the post-QRS phase automatically identified late potentials. In 25 of 27 left ventricular VT activation maps, a minimum spatial window of interest correctly identified the VT isthmus as seen by the manually annotated map, entrainment, and response to ablation. In 6 maps, the algorithm identified the isthmus where the standard automatically annotated map did not. The Lumipoint algorithm automatically highlights areas with electrograms having specific characteristics or timings. This can identify late and fractionated potentials and regions that exhibit discontinuous activation, as well as the isthmus of a VT circuit. These features may enhance human interpretation of the electrogram signals during a case, particularly where the circuit lies in partial scar with low amplitude nearfield signals and potentially allow a more targeted ablation strategy.

Sections du résumé

OBJECTIVES
This study reports the use of a novel "Lumipoint" algorithm in ventricular tachycardia (VT) ablation.
BACKGROUND
Automatic mapping systems aid rapid acquisition of activation maps. However, they may annotate farfield rather than nearfield signal in low voltage areas, making maps difficult to interpret. The Lumipoint algorithm analyzes the complete electrogram tracing and therefore includes nearfield signals in its analysis.
METHODS
Twenty-two patients with ischemic cardiomyopathy and 5 with dilated cardiomyopathy underwent mapping using the ultra-high density Rhythmia system. Lumipoint algorithms were applied retrospectively.
RESULTS
In all left ventricular substrate maps, changing the window of interest to the post-QRS phase automatically identified late potentials. In 25 of 27 left ventricular VT activation maps, a minimum spatial window of interest correctly identified the VT isthmus as seen by the manually annotated map, entrainment, and response to ablation. In 6 maps, the algorithm identified the isthmus where the standard automatically annotated map did not.
CONCLUSIONS
The Lumipoint algorithm automatically highlights areas with electrograms having specific characteristics or timings. This can identify late and fractionated potentials and regions that exhibit discontinuous activation, as well as the isthmus of a VT circuit. These features may enhance human interpretation of the electrogram signals during a case, particularly where the circuit lies in partial scar with low amplitude nearfield signals and potentially allow a more targeted ablation strategy.

Identifiants

pubmed: 31000101
pii: S2405-500X(19)30070-2
doi: 10.1016/j.jacep.2019.01.016
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

470-479

Informations de copyright

Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Auteurs

Claire A Martin (CA)

Electrophysiology and Ablation Unit, Bordeaux University Hospital (Centre Hospitalier Universitaire [CHU]), Pessac, France; Institut Hospitalo-Universitaire (IHU), LIRYC, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, Pessac- Bordeaux, France; Université Bordeaux, Institut National de la Santé et de la Recherche Médicale U1045, Bordeaux, France; Department of Electrophysiology, Royal Papworth Hospital National Health Service Foundation Trust, Cambridge, United Kingdom. Electronic address: clairemartin@gmail.com.

Masateru Takigawa (M)

Electrophysiology and Ablation Unit, Bordeaux University Hospital (Centre Hospitalier Universitaire [CHU]), Pessac, France; Institut Hospitalo-Universitaire (IHU), LIRYC, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, Pessac- Bordeaux, France; Université Bordeaux, Institut National de la Santé et de la Recherche Médicale U1045, Bordeaux, France.

Ruairidh Martin (R)

Electrophysiology and Ablation Unit, Bordeaux University Hospital (Centre Hospitalier Universitaire [CHU]), Pessac, France; Institut Hospitalo-Universitaire (IHU), LIRYC, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, Pessac- Bordeaux, France; Université Bordeaux, Institut National de la Santé et de la Recherche Médicale U1045, Bordeaux, France; Department of Cardiology, Newcastle University, Newcastle, United Kingdom.

Philippe Maury (P)

Unité Inserm U 1048, University Hospital Rangueil, Toulouse, France.

Christian Meyer (C)

Department of Cardiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Tom Wong (T)

Department of Electrophysiology, Brompton Hospital, London, United Kingdom.

Rui Shi (R)

Department of Electrophysiology, Brompton Hospital, London, United Kingdom.

Parag Gajendragadkar (P)

Department of Electrophysiology, Royal Papworth Hospital National Health Service Foundation Trust, Cambridge, United Kingdom.

Antonio Frontera (A)

Electrophysiology and Ablation Unit, Bordeaux University Hospital (Centre Hospitalier Universitaire [CHU]), Pessac, France; Institut Hospitalo-Universitaire (IHU), LIRYC, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, Pessac- Bordeaux, France; Université Bordeaux, Institut National de la Santé et de la Recherche Médicale U1045, Bordeaux, France.

Ghassen Cheniti (G)

Electrophysiology and Ablation Unit, Bordeaux University Hospital (Centre Hospitalier Universitaire [CHU]), Pessac, France; Institut Hospitalo-Universitaire (IHU), LIRYC, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, Pessac- Bordeaux, France; Université Bordeaux, Institut National de la Santé et de la Recherche Médicale U1045, Bordeaux, France.

Nathaniel Thompson (N)

Electrophysiology and Ablation Unit, Bordeaux University Hospital (Centre Hospitalier Universitaire [CHU]), Pessac, France; Institut Hospitalo-Universitaire (IHU), LIRYC, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, Pessac- Bordeaux, France; Université Bordeaux, Institut National de la Santé et de la Recherche Médicale U1045, Bordeaux, France.

Takeshi Kitamura (T)

Electrophysiology and Ablation Unit, Bordeaux University Hospital (Centre Hospitalier Universitaire [CHU]), Pessac, France; Institut Hospitalo-Universitaire (IHU), LIRYC, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, Pessac- Bordeaux, France; Université Bordeaux, Institut National de la Santé et de la Recherche Médicale U1045, Bordeaux, France.

Konstantinos Vlachos (K)

Electrophysiology and Ablation Unit, Bordeaux University Hospital (Centre Hospitalier Universitaire [CHU]), Pessac, France; Institut Hospitalo-Universitaire (IHU), LIRYC, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, Pessac- Bordeaux, France; Université Bordeaux, Institut National de la Santé et de la Recherche Médicale U1045, Bordeaux, France.

Michael Wolf (M)

Electrophysiology and Ablation Unit, Bordeaux University Hospital (Centre Hospitalier Universitaire [CHU]), Pessac, France; Institut Hospitalo-Universitaire (IHU), LIRYC, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, Pessac- Bordeaux, France; Université Bordeaux, Institut National de la Santé et de la Recherche Médicale U1045, Bordeaux, France.

Felix Bourier (F)

Electrophysiology and Ablation Unit, Bordeaux University Hospital (Centre Hospitalier Universitaire [CHU]), Pessac, France; Institut Hospitalo-Universitaire (IHU), LIRYC, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, Pessac- Bordeaux, France; Université Bordeaux, Institut National de la Santé et de la Recherche Médicale U1045, Bordeaux, France.

Anna Lam (A)

Electrophysiology and Ablation Unit, Bordeaux University Hospital (Centre Hospitalier Universitaire [CHU]), Pessac, France; Institut Hospitalo-Universitaire (IHU), LIRYC, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, Pessac- Bordeaux, France; Université Bordeaux, Institut National de la Santé et de la Recherche Médicale U1045, Bordeaux, France.

Josselin Duchâteau (J)

Electrophysiology and Ablation Unit, Bordeaux University Hospital (Centre Hospitalier Universitaire [CHU]), Pessac, France; Institut Hospitalo-Universitaire (IHU), LIRYC, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, Pessac- Bordeaux, France; Université Bordeaux, Institut National de la Santé et de la Recherche Médicale U1045, Bordeaux, France.

Grégoire Massoullié (G)

Electrophysiology and Ablation Unit, Bordeaux University Hospital (Centre Hospitalier Universitaire [CHU]), Pessac, France; Institut Hospitalo-Universitaire (IHU), LIRYC, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, Pessac- Bordeaux, France; Université Bordeaux, Institut National de la Santé et de la Recherche Médicale U1045, Bordeaux, France.

Thomas Pambrun (T)

Electrophysiology and Ablation Unit, Bordeaux University Hospital (Centre Hospitalier Universitaire [CHU]), Pessac, France; Institut Hospitalo-Universitaire (IHU), LIRYC, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, Pessac- Bordeaux, France; Université Bordeaux, Institut National de la Santé et de la Recherche Médicale U1045, Bordeaux, France.

Arnaud Denis (A)

Electrophysiology and Ablation Unit, Bordeaux University Hospital (Centre Hospitalier Universitaire [CHU]), Pessac, France; Institut Hospitalo-Universitaire (IHU), LIRYC, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, Pessac- Bordeaux, France; Université Bordeaux, Institut National de la Santé et de la Recherche Médicale U1045, Bordeaux, France.

Nicolas Derval (N)

Electrophysiology and Ablation Unit, Bordeaux University Hospital (Centre Hospitalier Universitaire [CHU]), Pessac, France; Institut Hospitalo-Universitaire (IHU), LIRYC, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, Pessac- Bordeaux, France; Université Bordeaux, Institut National de la Santé et de la Recherche Médicale U1045, Bordeaux, France.

Mélèze Hocini (M)

Electrophysiology and Ablation Unit, Bordeaux University Hospital (Centre Hospitalier Universitaire [CHU]), Pessac, France; Institut Hospitalo-Universitaire (IHU), LIRYC, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, Pessac- Bordeaux, France; Université Bordeaux, Institut National de la Santé et de la Recherche Médicale U1045, Bordeaux, France.

Michel Haïssaguerre (M)

Electrophysiology and Ablation Unit, Bordeaux University Hospital (Centre Hospitalier Universitaire [CHU]), Pessac, France; Institut Hospitalo-Universitaire (IHU), LIRYC, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, Pessac- Bordeaux, France; Université Bordeaux, Institut National de la Santé et de la Recherche Médicale U1045, Bordeaux, France.

Pierre Jaïs (P)

Electrophysiology and Ablation Unit, Bordeaux University Hospital (Centre Hospitalier Universitaire [CHU]), Pessac, France; Institut Hospitalo-Universitaire (IHU), LIRYC, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, Pessac- Bordeaux, France; Université Bordeaux, Institut National de la Santé et de la Recherche Médicale U1045, Bordeaux, France.

Frédéric Sacher (F)

Electrophysiology and Ablation Unit, Bordeaux University Hospital (Centre Hospitalier Universitaire [CHU]), Pessac, France; Institut Hospitalo-Universitaire (IHU), LIRYC, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, Pessac- Bordeaux, France; Université Bordeaux, Institut National de la Santé et de la Recherche Médicale U1045, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH